ESLA: Estrella Immunopharma, Inc. Stock

by  •  • Comments Off on ESLA: Estrella Immunopharma, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 39.17
Enterprise Value ($M) 30.13
Book Value ($M) 9.05
Book Value / Share 0.25
Price / Book 4.33
NCAV ($M) 9.05
NCAV / Share 0.25
Price / NCAV 4.33

Profitability (mra)
Return on Invested Capital (ROIC) -0.92
Return on Assets (ROA) -2.70
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 23.69
Current Ratio 23.69

Balance Sheet (mrq) ($M)
Current Assets 9.45
Assets 9.45
Liabilities 0.40
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
10-30 13D Eureka Therapeutics, Inc. 71.80 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 ☐ TRANSITION REPORT PURS
2023-11-20 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PUR

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-13 2,943 12,478 23.59
2024-05-10 375 6,520 5.75
2024-05-09 21 213 9.86
2024-05-08 489 150 326.00

(click for more detail)

Similar Companies
EPIX – ESSA Pharma Inc. EQ – Equillium, Inc.
ERNA – Eterna Therapeutics Inc. EVOK – Evoke Pharma, Inc.
EYEN – Eyenovia, Inc.


Financial data and stock pages provided by
Fintel.io